| 22/490 |
Oncotype Use for Breast Cancer |
| 22/489 |
New Hospital Programme |
| 22/486 |
Microsoft 11 |
| 22/485 |
Drug Treatments |
| 22/483 |
Maternity Figures |
| 22/481 |
Haemophilia A |
| 22/478 |
Agency Usage |
| 22/477 |
PrEP Medication |
| 22/475 |
New Biologic Medications Within Dermatology |
| 22/474 |
Reinforced Autoclaved Aerated Concrete |
| 22/472 |
Stillbirth & Infant Deaths |
| 22/471 |
ACR Laboratory Device |
| 22/469 |
CT and MRI Machines |
| 22/465 |
Electronic Patient Record System |
| 22/464 |
Long Covid Clinics |
| 22/463 |
Respiratory |
| 22/460 |
Hospital-Initiated Cancellation of Appointments |
| 22/457 |
Diversity |
| 22/447 |
FTE Physiotherapists |
| 22/443 |
Accident and Emergency Departments |
